Knowledge hub

Blog

Blog

One-Week Transition to Cloud Infrastructure for Biotech Companies

Antibody Hit Screening: Developing Successful Therapies with the Help of In Silico Tools
Target Identification: The Cornerstone of the Drug Discovery Process
AI Meets Biologics: Highlights from the Festival of Biologics 2024
Driving better drug discovery: smarter data, smarter decisions
BioTechX Europe recap: Trends, innovations, and insights
One-Week Transition to Cloud Infrastructure for Biotech Companies
Recent Successes in Phenotypic Drug Discovery and the Future of ML/AI Methods
Ardigen phenAID’s Multimodal Approach Improves MoA and Bioactivity Prediction When Applied to a HCS Dataset from a Big Pharma Company
Blog

High Content Screening: Redefining What Is Possible with Artificial Intelligence and Machine Learning

AI-Powered Breakthroughs in Antibody Optimization
AI Brain Slice Segmentation – Innovative Solutions for Precision Diagnostics
AI at the Forefront of Modern Radiology Analysis: Brain MRI Use Case
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
Gut microbiota’s road to clinical utilization. From bathroom to bedside.
Off-the-Shelf allogeneic cellular immunotherapies for cancer
Current and future directions in CAR-T and TCR-T cell therapies against solid tumors
Conformal Prediction in Classification